Novel zinc(II) complexes [Zn(atc-Et)2] and [Zn(atc-Ph)2]: In vitro and in vivo antiproliferative studies

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  De Lopes, Erica O ^a   De Oliveira, Carolina G ^b   Da Silva, Patricia B ^a   Eismann, Carlos E ^a   Suárez, Carlos A ^a   Menegário, Amauri A ^a   Leite, Clarice Q F ^a   Deflon, Victor M ^b   Pavan, Fernando R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute toxicity; Antiproliferative activity; Artemia salina L; Cancer; Oral bioavailability; Zinc(II) complexes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; ZINC ION; ANTINEOPLASTIC AGENT; THIOSEMICARBAZONE DERIVATIVE; ZINC;

ACUTE TOXICITY; ANIMAL BEHAVIOR; ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTEMIA SALINA; ARTICLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONDUCTOMETRY; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION; ANIMAL; ARTEMIA; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HEP-G2 CELL LINE; IN VITRO STUDY; SYNTHESIS; TOXICITY TESTING; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ARTEMIA; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CELL PROLIFERATION; HELA CELLS; HEP G2 CELLS; HUMANS; IN VITRO TECHNIQUES; MICE; MOLECULAR STRUCTURE; THIOSEMICARBAZONES; TOXICITY TESTS, ACUTE; ZINC;

EID: 85015593408     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050781     Document Type: Article

References (38)

1. World Health Organization (WHO). Available online: http://www.who.int/mediacentre/factsheets/fs297/es/ (accessed on 6 April 2015).
2. American Cancer Society. Available online: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/ (accessed on 15 May 2015).
3. National Cancer Institute (NCI). Available online: www.cancer.gov/about-cancer/treatment/types (accessed on 6 April 2015).
4. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 2007, 7, 573–584. [CrossRef] [PubMed]
5. Bielawski, K.; Czarnomysy, R.; Muszynska, A.; Bielawska, A.; Poplawska, B. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes. Environ. Toxicol. Pharmacol. 2013, 35, 254–264. [CrossRef] [PubMed]
6. Zhang, Z.; Xie, Z.; Sun, G.; Yang, P.; Li, J.; Yang, H.; Xiao, S.; Liu, Y.; Qiu, H.; Qiu, L. et al. Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells. Int. J. Clin. Exp. Med. 2015, 8, 687–701.
7. Wu, H.M.; Jiang, Z.F.; Ding, P.S.; Shao, L.J.; Lui, R.Y. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells. Sci. Rep. 2015, 5, 1–15. [CrossRef] [PubMed]
8. Valenzuela, M.M.; Neidigh, J.W.; Wall, N.R. Antimetabolite treatment for pancreatic cancer. Chemotherapy (Los Angel) 2014, 3, 1–16.
9. Liu, Z.; Lui, J.; Li, L.; Nie, D.; Tao, Q.; Wu, J.; Fan, J.; Lin, C.; Zhao, S.; Ju, D. Inhibition of autophagy potentiated the antitumor effect of nedaplatin in cisplatin-resistant nasopharyngeal carcinoma cells. PLoS ONE 2015, 10, 1–16. [CrossRef] [PubMed]
10. Florea, A.M.; Busselberg, D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 2011, 3, 1351–1371. [CrossRef] [PubMed]
11. Do Nascimento, F.B.; Poelhsitz, G.V.; Pavan, F.R.; Sato, D.N.; Leite, C.Q.F.; Araújo, H.S.S.; Ellena, J.; Castellano, E.E.; Deflon, V.M.; Bastista, A.A. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine. J. Inorg. Biochem. 2008, 102, 1783–1789. [CrossRef] [PubMed]
12. Mondelli, M.A.; Graminha, A.E.; Côrrea, R.S.; Silva, M.M.; Carnizello, A.P.; Poelhsitz, G.V.; Ellena, J.; Deflon, V.M.; Caramori, G.F.; Torre, M.H. et al. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines. Polyhedron 2014, 68, 312–318. [CrossRef]
13. Malone, R. Bioinorganic Chemistry: A Short Course, 2nd ed.; JohnWiley & Sons: New Jersey, NJ, USA, 2002; pp. 1–368.
14. Das, A.K. Metallotherapy: A Textbook on Medicinal Aspects of Bioinorganic Chemistry; CBS Publishers and Distributors: New Dehli, India, 1990.
15. Li, M.X.; Zhang, L.Z.; Yang, M.; Niu, J.Y.; Zhou, J. Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone. Bioorg. Med. Chem. Lett. 2012, 22, 2418–2423. [CrossRef] [PubMed]
16. Li, M.X.; Chen, C.L.; Zhang, D.; Niu, J.Y.; Ji, B.S. Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: Synthesis, characterization, X-ray crystal structures and antitumor comparison. Eur. J. Med. Chem. 2010, 45, 3169–3177. [CrossRef] [PubMed]
17. Oliveira, C.G.; Maia, P.I.S.; Souza, P.C.; Pavan, F.R.; Leite, C.Q.F.; Vianna, R.B.; Batista, A.A.; Nascimento, O.R.; Deflon, V.M. Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents. J. Inorg. Biochem. 2013, 132, 21–29. [CrossRef] [PubMed]
18. Oliveira, C.G.; Maia, P.I.S.; Miyata, M.; Pavan, F.R.; Leite, C.Q.F.; Almeida, E.T.; Deflon, V.M. Cobalt(III) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents. J. Braz. Chem. Soc. 2014, 25, 1848–1856.
19. Stefani, C.; Jansson, P.J.; Gutierrez, E.; Bernhardt, P.V.; Richardson, D.R.; Kalinowski, D.S. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: Novel ligands that limit methemoglobin formation. J. Med. Chem. 2013, 56, 357–370. [CrossRef] [PubMed]
20. Chelopo, M.P.; Pawar, S.A.; Sokhela, M.K.; Govender, T.; Kruger, H.G.; Maguire, G.E.M. Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands. Eur. J. Med. Chem. 2013, 66, 407–414. [CrossRef] [PubMed]
21. Parra, A.L.; Yhebra, R.S.; Sardiñas, I.G.; Buela, L.I. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. Phytomedicine 2001, 8, 395–400.
22. Meyer, B.N.; Ferrigni, N.R.; Putnam, J.E.; Jacobsen, L.B.; Nichols, D.E.; McLaughlin, J.L. Brine shrimp: A convenient general bioassay for active plant constituents. Planta Med. 1982, 45, 31–34. [CrossRef] [PubMed]
23. Ferraz, K.O.; Wardell, S.M.S.V.; Wardell, J.L.; Louro, S.R.W.; Beraldo, H. Copper(II) complexes with 2-pyridineformamide-derived thiosemicarbazones: Spectral studies and toxicity against Artemia salina. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2009, 73, 140–145. [CrossRef] [PubMed]
24. Krstic, N.M.; Matuc, I.Z.; Juranic, Z.D.; Novakovic, I.T.; Sladic, D.M. Steroid dimers-in vitro cytotoxic and antimicrobial activities. J. Steroid Biochem. Mol. Biol. 2014, 143, 365–375. [CrossRef] [PubMed]
25. Freitas, M.C.R.; Antonio, J.M.S.; Ziolli, R.L.; Yoshida, M.I.; Rey, N.A.; Diniz, R. Synthesis and structural characterization of a zinc(II) complex of the mycobactericidal drug isoniazid—Toxicity against Artemia salina. Polyhedron 2011, 30, 1922–1926. [CrossRef]
26. OECD, 2011. Guideline 423: Acute Oral Toxicity - Acute Toxic Class Method. Paris: Head of Publications Service. Available online: http://www.oecd.org/publications (accessed on 18 November 2014).
27. Muscella, A.; Vetrugno, C.; Migoni, D.; Biagioni, F.; Fanizzi, F.P.; Fornai, F.; De Pascali, S.A.; Marsigliante, S. Antitumor activity of [Pt(O,O1-acac)(gamma-acac)(DMS)] in mouse xenograft model of breast cancer. Cell. Death Dis. 2014, 5, 1014. [CrossRef] [PubMed]
28. Piao, Y.; Liu, Y.; Xiel, X. Change trends of organ weight background data in sprague dawley rats at diferente ages. J. Toxicol. Pathol. 2013, 26, 29–34. [CrossRef] [PubMed]
29. Ping, K.Y.; Darah, I.; Chen, Y.; Sreeramanan, S.; Sasidharan, S. Acute and subchronic toxicity study of Euphorbia hirta L. methanol extract in rats. BioMed Res. Int. 2013, 2013, 1–14. [CrossRef] [PubMed]
30. Huang, X.-J.; Choi, Y.-K.; Im, H.-S.; Yarimaga, O.; Yoon, E.; Kim, H.-S. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors 2006, 6, 756–782. [CrossRef]
31. Araujo, R.C.P.; Neves, F.A.R.; Formagio, A.S.N.; Kasseya, C.A.L.; Stefanello, M.E.A.; Souza, V.V.; Pavan, F.R.; Croda, J. Evaluation of the anti-mycobacterium tuberculosis activity and in vivo acute toxicity of Annona sylvatic. BMC Complement. Altern. Med. 2014, 14, 209. [CrossRef] [PubMed]
32. Zhang, S.; Zhang, Y.; Peng, N.; Zhang, H.; Yao, J.; Li, Z.; Liu, L. Pharmacokinetics and biodistribution of zinc-enriched yeast in rats. Sci. World J. 2014, 2014, 1–4. [CrossRef] [PubMed]
33. G.M. Sheldrick, SHELXL 97. Program. for the Refinement of Crystal Structures; University of Göttingen: Göttingen, Germany, 1997.
34. O’brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421–5426. [CrossRef] [PubMed]
35. Akhtar, M.N.; Zareen, S.; Yeap, S.K.; Ho, W.Y.; Lo, K.M.; Hasan, A.; Alitheen, B. Total synthesis, cytotoxic effects of damnacanthal, nordamnacanthal and related anthraquinone analogues. Molecules 2013, 18, 10042–10055. [CrossRef] [PubMed]
36. Gruppo, V.; Johnson, C.M.; Marietta, K.S.; Scherman, H.; Zink, E.E.; Crick, D.C.; Adams, L.B.; Orme, I.M.; Lenaerts, J.A. Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2006, 50, 1245–1250. [CrossRef] [PubMed]
37. Golde, W.T.; Gollobin, P.; Rodriguez, L.L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. 2005, 34, 39–43. [CrossRef] [PubMed]
38. Batista, B.L.; Rodrigues, J.L.; Nunes, J.A.; Souza, V.C.O.; Barbosa, F.J. Exploiting dynamic reaction cell inductively coupled plasma mass spectrometry (DRC-ICP-MS) for sequential determination of trace elements in blood using a dilute-and-shoot procedure. Anal. Chim. Acta 2009, 639, 13–18. [CrossRef] [PubMed]